Pet Innovation Awards in Los Angeles on Aug. 13, 2025.

The prize recognizes new products judged to advance canine health; Longevity15 is marketed as a science-backed supplement formulated to support long-term health and wellness at the cellular level. The product contains greater than 99% pure C15:0 fatty15 powder, delivered without oils or fishy taste. This innovative formulation is particularly relevant at a time when common dog health issues like dog health issues like skin allergies, ear infections, and joint disorders are on the rise.

The Pet Innovation Awards honors innovative companies and products across the pet care sector, and the 2025 program singled out Longevity15 for its approach to supplementing a single-chain saturated fatty acid, C15:0, aimed at dogs of all breeds and sizes. The awards program name is linked to the announcement on GlobeNewswire.

Pet’s Best Life said it partnered with Seraphina Therapeutics to commercialize C15:0 for canine use; Seraphina Therapeutics appears on the company roster as the collaborator on the ingredient. The partnership is central to the product’s positioning as a targeted supplement derived from the patented fatty15 technology. This collaboration comes at a time when the pet health industry is increasingly focusing on preventive and comprehensive wellness care, emphasizing the importance of routine vet visits and personalized care plans.

“If you value and cherish your dogs like we do, then Longevity15 is meant for your dog. Dogs can’t produce C15:0, so these good fats must be obtained from diet or supplements. We are thrilled to team up with Dr. Venn-Watson to introduce this incredible supplement backed by years of proven science,” said Dr. Joe Roetheli, CEO of Pet’s Best Life. Industry surveys have found that many dog owners are willing to pay more for pet foods that promote health and wellness, reflecting growing consumer demand for quality pet care products.

Independent Innovation Awards Managing Director Travis Grant framed the win in consumer terms: “If you want your dog to live a healthier and happier quality of life, and what dog lover doesn’t, Longevity15 provides that opportunity,” he said. This notion echoes broader industry trends where pet owners are prioritizing health products when choosing care for their animals.

Company materials describe the product as designed for use across life stages and breeds. Pet’s Best Life also markets complementary items in its portfolio, and it positioned Longevity15 as part of a broader effort to offer science-based options for pet owners. The recognition from the Pet Innovation Awards positions the product for attention from veterinarians, retailers, and owners looking for novel health supplements for dogs.

The award places Longevity15 among a slate of winners that the Pet Innovation Awards selects each year to highlight developments in food, health, grooming, and accessories. Industry observers have pointed to a shift toward premium, science-backed offerings in recent years; this context aligns with the increasing importance of health products in pet care, driven by more informed pet owners.

Dr. Steph Venn-Watson of Seraphina Therapeutics is identified as the collaborator with Pet’s Best Life on commercialization of the C15:0 ingredient. Company statements emphasize the purity of the ingredient and its delivery format as differentiators for pet owners seeking supplementation without strong tastes or oils. Longevity15 stands as a key example of how targeted nutritional advancements can contribute to the well-being of dogs, aligning with the industry’s ongoing evolution.

The award announcement on Aug. 13, 2025, gives Pet’s Best Life a platform to promote Longevity15 ahead of wider distribution plans tied to the Seraphina collaboration. The recognition enhances the visibility of Longevity15 in a market where proper nutrition and supplementation are now recognized as critical elements of dog health.

Source

Original reporting: view the original article.